Le Bar-sur-Loup, France

Romain Bachelard

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: St IP Holding Ag. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Romain Bachelard. Retrieved from https://idiyas.com/inventor/romain-bachelard

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Romain Bachelard: Innovator in Pharmaceutical Formulations

Introduction

Romain Bachelard is a notable inventor based in Le Bar-sur-Loup, France. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of taste-modified compositions.

Latest Patents

Bachelard holds a patent for "Formulations of 4-methyl-5-(pyrazin-2-yl)-3H-l,2-dithiole-3-thione, taste-modified formulations, and methods of making and using same." This patent provides compositions that include quantities of oltipraz crystals, along with methods for creating these compositions and treating patients with them. The innovation also encompasses taste-modified compositions, enhancing the usability of the formulations.

Career Highlights

Bachelard's work has been instrumental in advancing pharmaceutical formulations. His focus on taste-modified compositions addresses a critical need in patient compliance and medication administration.

Collaborations

Bachelard has collaborated with notable colleagues, including Anthony Chris Garland and Barbara-Jean Anne Bormann-Kennedy, contributing to the development of innovative solutions in his field.

Conclusion

Romain Bachelard's contributions to pharmaceutical formulations highlight his role as an innovator in the industry. His patent work and collaborations reflect a commitment to improving patient care through enhanced medication formulations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…